Related references
Note: Only part of the references are listed.Pharmacologic inhibition of the enzymatic effects of tissue transglutaminase reduces cardiac fibrosis and attenuates cardiomyocyte hypertrophy following pressure overload
Arti V. Shinde et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2018)
Tissue transglutaminase induces Epithelial-Mesenchymal-Transition and the acquisition of stem cell like characteristics in colorectal cancer cells
Oluseyi Ayinde et al.
ONCOTARGET (2017)
Tissue transglutaminase induction in the pressure-overloaded myocardium regulates matrix remodelling
Arti V. Shinde et al.
CARDIOVASCULAR RESEARCH (2017)
A novel regulatory role for tissue transglutaminase in epithelial-mesenchymal transition in cystic fibrosis
Samuel Nyabam et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2016)
Cardiac fibrosis in myocardial infarction-from repair and remodeling to regeneration
Virpi Talman et al.
CELL AND TISSUE RESEARCH (2016)
Partial Epithelial-to-Mesenchymal Transition and Other New Mechanisms of Kidney Fibrosis
Sara Lovisa et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2016)
Genetic lineage tracing defines myofibroblast origin and function in the injured heart
Onur Kanisicak et al.
NATURE COMMUNICATIONS (2016)
Endothelial to Mesenchymal Transition (EndoMT) in the Pathogenesis of Human Fibrotic Diseases
Sonsoles Piera-Velazquez et al.
JOURNAL OF CLINICAL MEDICINE (2016)
Development of Potent and Selective Tissue Transglutaminase Inhibitors: Their Effect on TG2 Function and Application in Pathological Conditions
Eduard Badarau et al.
CHEMISTRY & BIOLOGY (2015)
Origin of myofibroblasts and cellular events triggering fibrosis
Matthias Mack et al.
KIDNEY INTERNATIONAL (2015)
Celiac disease patient IgA antibodies induce endothelial adhesion and cell polarization defects via extracellular transglutaminase 2
Cristina Antonella Nadalutti et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2014)
Increased concentration of circulating angiogenesis and nitric oxide inhibitors induces endothelial to mesenchymal transition and myocardial fibrosis in patients with chronic kidney disease
David M. Charytan et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2014)
Discovery of Potent and Specific Dihydroisoxazole Inhibitors of Human Transglutaminase 2
Cornelius Kloeck et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Extracellular thioredoxin: A therapeutic tool to combat inflammation
Yoshiyuki Matsuo et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2013)
Imidazolium-based warheads strongly influence activity of water-soluble peptidic transglutaminase inhibitors
Eduard Badarau et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2013)
Characterization of Heparin-binding Site of Tissue Transglutaminase ITS IMPORTANCE IN CELL SURFACE TARGETING, MATRIX DEPOSITION, AND CELL SIGNALING
Zhuo Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Transglutaminase 2 and Its Role in Pulmonary Fibrosis
Keith C. Olsen et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2011)
Aldosterone and aldosterone receptor antagonists in patients with chronic heart failure
Jean M. Nappi et al.
VASCULAR HEALTH AND RISK MANAGEMENT (2011)
The Origin of Fibroblasts and Mechanism of Cardiac Fibrosis
Guido Krenning et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2010)
TGF-β Superfamily Signaling in Embryonic Development and Homeostasis
Mary Y. Wu et al.
DEVELOPMENTAL CELL (2009)
Cardiac fibroblasts: At the heart of myocardial remodeling
Karen E. Porter et al.
PHARMACOLOGY & THERAPEUTICS (2009)
Role of transforming growth factor-beta superfamily signaling pathways in human disease
Kelly J. Gordon et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2008)
Fibroblasts in Kidney Fibrosis Emerge via Endothelial-to-Mesenchymal Transition
Elisabeth M. Zeisberg et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2008)
Matrix changes induced by transglutaminase 2 lead to inhibition of angiogenesis and tumor growth
R. A. Jones et al.
CELL DEATH AND DIFFERENTIATION (2006)
TGF-β superfamily members and ovarian follicle development
Phil G. Knight et al.
REPRODUCTION (2006)
Structural and functional characterisation of cardiac fibroblasts
P Camelliti et al.
CARDIOVASCULAR RESEARCH (2005)
Fibrosis and ischemia: The real risks in hypertensive heart disease
ED Frohlich
AMERICAN JOURNAL OF HYPERTENSION (2001)